Cargando…

High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders

Treatment discontinuation is a major challenge in routine clinical settings. Despite poor adherence to antipsychotic medication, long acting injectable (LAI) formulations are an underutilized option in psychotic disorders. Recently, an earlier and broader use of LAIs has been emphasized. However, fe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Auxilia, Anna Maria, Buoli, Massimiliano, Caldiroli, Alice, Carnevali, Greta Silvia, Tringali, Agnese, Nava, Roberto, Clerici, Massimo, Capuzzi, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953565/ https://www.ncbi.nlm.nih.gov/pubmed/36830850 http://dx.doi.org/10.3390/biomedicines11020314

Ejemplares similares

Is there an association between inflammatory/anti-oxidant markers and the presence of psychotic symptoms or severity of illness in mood and psychotic disorders? A multi-centric study on a drug-free sample
por: Caldiroli, Alice, et al.
Publicado: (2022)

Biological Predictors of Treatment Response in Adult Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review
por: Capuzzi, Enrico, et al.
Publicado: (2022)

Psychiatric emergency care during Coronavirus 2019 (COVID 19) pandemic lockdown: results from a Department of Mental Health and Addiction of northern Italy
por: Capuzzi, Enrico, et al.
Publicado: (2020)

Sociodemographic and clinical characteristics associated with delirium in hospitalized patients with COVID-19: are immigrants a vulnerable group?
por: Capuzzi, Enrico, et al.
Publicado: (2023)

Screening for ADHD Symptoms among Criminal Offenders: Exploring the Association with Clinical Features
por: Capuzzi, Enrico, et al.
Publicado: (2022)

The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from different mental disorders: An observational retrospective study
por: Caldiroli, Alice, et al.
Publicado: (2022)

Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review
por: Capuzzi, Enrico, et al.
Publicado: (2021)

Experimental Serotonergic Agents for the Treatment of Schizophrenia
por: Capuzzi, Enrico, et al.
Publicado: (2021)

Are There Any Differences in Clinical and Biochemical Variables between Bipolar Patients with or without Lifetime Psychotic Symptoms?
por: Esposito, Cecilia Maria, et al.
Publicado: (2023)

Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
por: Biagi, Enrico, et al.
Publicado: (2017)

Candidate Biological Markers for Social Anxiety Disorder: A Systematic Review
por: Caldiroli, Alice, et al.
Publicado: (2023)

Clinical Markers of Panic and Generalized Anxiety Disorder: Overlapping Symptoms, Different Course and Outcome
por: Caldiroli, Alice, et al.
Publicado: (2023)

Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review
por: Caldiroli, Alice, et al.
Publicado: (2021)

Are there any differences in clinical and biochemical variables between bipolar patients with or without lifetime psychotic symptoms?
por: Esposito, C. M., et al.
Publicado: (2023)

Clinical and biochemical parameters associated with substance-induced psychotic disorder: which differences between alcohol, cannabis and psychostimulants
por: Nosari, G., et al.
Publicado: (2023)

Delirium in COVID-19 hospitalized patients: sociodemographic and clinical correlates in a small cohort of patients in Northern Italy
por: Cella, F., et al.
Publicado: (2022)

Clinical and Peripheral Biomarkers in Female Patients Affected by Anorexia: Does the Neutrophil/Lymphocyte Ratio (NLR) Affect Severity?
por: Caldiroli, Alice, et al.
Publicado: (2023)

Which Clinical and Biochemical Parameters Are Associated with Lifetime Suicide Attempts in Bipolar Disorder?
por: Surace, Teresa, et al.
Publicado: (2022)

What has the impact of the Coronavirus 2019 (COVID 19) pandemic lockdown been on mental health among young adults?
por: Scalia, A., et al.
Publicado: (2022)

Air Pollution and Perinatal Mental Health: A Comprehensive Overview
por: Surace, Teresa, et al.
Publicado: (2023)

The Impact of the COVID-19 Pandemic on Binge Eating Disorder: A Systematic Review
por: Caldiroli, Alice, et al.
Publicado: (2023)

Clinical and Biological Factors Are Associated with Treatment-Resistant Depression
por: Buoli, Massimiliano, et al.
Publicado: (2022)

P.0638 Comparing the psychological impact of COVID-19 pandemic between psychiatric patients and healthy subjects: an observational retrospective study from northern Italy
por: Turco, M., et al.
Publicado: (2021)

P.0447 The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from mental disorders: an observational retrospective study
por: Caldiroli, A., et al.
Publicado: (2021)

Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics
por: Ventriglio, Antonio, et al.
Publicado: (2019)

Use of Psychoeducation for Psychotic Disorder Patients Treated With Modern, Long-Acting, Injected Antipsychotics
por: Ventriglio, Antonio, et al.
Publicado: (2021)

Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics
por: Mahlich, Jörg, et al.
Publicado: (2020)

Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-10
por: Tatini, Lorenzo, et al.
Publicado: (2021)

Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data
por: Caballero, Joshua, et al.
Publicado: (2023)

Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study
por: Buoli, Massimiliano, et al.
Publicado: (2012)

Attitudes of European physicians towards the use of long-acting injectable antipsychotics
por: Patel, Maxine X., et al.
Publicado: (2020)

Age at Onset and Social Cognitive Impairment in Clinically Stabilized Patients with Schizophrenia: An Ecological Cross-Sectional Study
por: Caldiroli, Alice, et al.
Publicado: (2018)

Rehospitalization Rates Among Patients with Psychotic Disorders During Covid-19 Pandemic: Oral Versus Long-Acting Injectable Antipsychotics
por: Mastelić, Tonći, et al.
Publicado: (2022)

An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders
por: Crellin, Nadia E., et al.
Publicado: (2022)

Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review
por: Kishi, Taro, et al.
Publicado: (2021)

Augmentative Asenapine in a Recurrent Manic Catatonic Patient with Partial Response to Clozapine
por: Buoli, Massimiliano, et al.
Publicado: (2013)

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
por: Miyamoto, Seiya, et al.
Publicado: (2017)

Comparison of Efficacy and Safety between Long-Acting Injectable Antipsychotic Monotherapy and Combination of Long-Acting Injectable and Oral Antipsychotics in Patients with Schizophrenia
por: Sathienluckana, Thanompong, et al.
Publicado: (2021)

Clinical and economic impact of long-acting injectable antipsychotics in patients previously treated with short-acting oral antipsychotics
por: Kheloussi, Steven, et al.
Publicado: (2022)

Risk factors for psychotic relapse in chronic schizophrenia after dose-reduction or discontinuation of antipsychotics. A systematic review and meta-analysis
por: Bogers, J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_thsp2u8kj84dk3b6jlooikdr4n